|
1
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim CF, Jackson EL, Woolfenden AE,
Lawrence S, Babar I, Vogel S, Crowley D, Bronson RT and Jacks T:
Identification of bronchioalveolar stem cells in normal lung and
lung cancer. Cell. 121:823–835. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li F, Tiede B, Massagué J and Kang Y:
Beyond tumorigenesis: Cancer stem cells in metastasis. Cell Res.
17:3–14. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li C, Heidt DG, Dalerba P, Burant CF,
Zhang L, Adsay V, Wicha M, Clarke MF and Simeone DM: Identification
of pancreatic cancer stem cells. Cancer Res. 67:1030–1037. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shmelkov SV, St Clair R, Lyden D and Rafii
S: AC133/CD133/Prominin-1. Int J Biochem Cell Biol. 37:715–719.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hermann PC, Huber SL, Herrler T, Aicher A,
Ellwart JW, Guba M, Bruns CJ and Heeschen C: Distinct populations
of cancer stem cells determine tumor growth and metastatic activity
in human pancreatic cancer. Cell Stem Cell. 1:313–323. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
O'Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Paduch R: The role of lymphangiogenesis
and angiogenesis in tumor metastasis. Cell Oncol (Dordr).
39:397–410. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Japanese Society for Cancer of the Colon
and Rectum: Japanese Classification of Colorectal, Appendiceal, and
Anal Carcinoma: The 3d English Edition [Secondary Publication]. J
Anus Rectum Colon. 3:175–195. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hashiguchi Y, Muro K, Saito Y, Ito Y,
Ajioka Y, Hamaguchi T, Hasegawa K, Hotta K, Ishida H, Ishiguro M,
et al Japanese Society for Cancer of the Colon Rectum, : Japanese
Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019
for the treatment of colorectal cancer. Int J Clin Oncol. 25:1–42.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gilkes DM, Semenza GL and Wirtz D: Hypoxia
and the extracellular matrix: Drivers of tumour metastasis. Nat Rev
Cancer. 14:430–439. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pennacchietti S, Michieli P, Galluzzo M,
Mazzone M, Giordano S and Comoglio PM: Hypoxia promotes invasive
growth by transcriptional activation of the met protooncogene.
Cancer Cell. 3:347–361. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Semenza GL and Wang GL: A nuclear factor
induced by hypoxia via de novo protein synthesis binds to the human
erythropoietin gene enhancer at a site required for transcriptional
activation. Mol Cell Biol. 12:5447–5454. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hongo K, Tsuno NH, Kawai K, Sasaki K,
Kaneko M, Hiyoshi M, Murono K, Tada N, Nirei T, Sunami E, et al:
Hypoxia enhances colon cancer migration and invasion through
promotion of epithelial-mesenchymal transition. J Surg Res.
182:75–84. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
de Cuba EM, Kwakman R, van Egmond M, Bosch
LJ, Bonjer HJ, Meijer GA and te Velde EA: Understanding molecular
mechanisms in peritoneal dissemination of colorectal cancer: Future
possibilities for personalised treatment by use of biomarkers.
Virchows Arch. 461:231–243. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Giancotti FG and Ruoslahti E: Integrin
signaling. Science. 285:1028–1032. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Oosterling SJ, van der Bij GJ, Bögels M,
ten Raa S, Post JA, Meijer GA, Beelen RH and van Egmond M:
Anti-beta1 integrin antibody reduces surgery-induced adhesion of
colon carcinoma cells to traumatized peritoneal surfaces. Ann Surg.
247:85–94. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hongo K, Tanaka J, Tsuno NH, Kawai K,
Nishikawa T, Shuno Y, Sasaki K, Kaneko M, Hiyoshi M, Sunami E, et
al: CD133(−) cells, derived from a single human colon cancer cell
line, are more resistant to 5-fluorouracil (FU) than CD133(+)
cells, dependent on the β1-integrin signaling. J Surg Res.
175:278–288. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kishikawa J, Kazama S, Oba K, Hasegawa K,
Anzai H, Harada Y, Abe H, Matsusaka K, Hongo K, Oba M, et al: CD133
expression at the metastatic site predicts patients' outcome in
colorectal cancer with synchronous liver metastasis. Ann Surg
Oncol. 23:1916–1923. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Maeda K, Ding Q, Yoshimitsu M, Kuwahata T,
Miyazaki Y, Tsukasa K, Hayashi T, Shinchi H, Natsugoe S and Takao
S: CD133 modulate HIF-1alpha expression under hypoxia in EMT
phenotype pancreatic cancer stem-like cells. Int J Mol Sci.
17:10252016. View Article : Google Scholar
|
|
27
|
Salnikov AV, Liu L, Platen M, Gladkich J,
Salnikova O, Ryschich E, Mattern J, Moldenhauer G, Werner J,
Schemmer P, et al: Hypoxia induces EMT in low and highly aggressive
pancreatic tumor cells but only cells with cancer stem cell
characteristics acquire pronounced migratory potential. PLoS One.
7:e463912012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen YS, Wu MJ, Huang CY, Lin SC, Chuang
TH, Yu CC and Lo JF: CD133/Src axis mediates tumor initiating
property and epithelial-mesenchymal transition of head and neck
cancer. PLoS One. 6:e280532011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mitsui H, Shibata K, Suzuki S, Umezu T,
Mizuno M, Kajiyama H and Kikkawa F: Functional interaction between
peritoneal mesothelial cells and stem cells of ovarian yolk sac
tumor (SC-OYST) in peritoneal dissemination. Gynecol Oncol.
124:303–310. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Neumann J, Löhrs L, Albertsmeier M, Reu S,
Guba M, Werner J, Kirchner T and Angele M: Cancer stem cell markers
are associated with distant hematogenous liver metastases but not
with peritoneal carcinomatosis in colorectal cancer. Cancer Invest.
33:354–360. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nagata H, Ishihara S, Kishikawa J, Sonoda
H, Murono K, Emoto S, Kaneko M, Sasaki K, Otani K, Nishikawa T, et
al: CD133 expression predicts post-operative recurrence in patients
with colon cancer with peritoneal metastasis. Int J Oncol.
52:721–732. 2018.PubMed/NCBI
|
|
32
|
Kawai K, Tsuno NH, Kitayama J, Okaji Y,
Yazawa K, Asakage M, Hori N, Watanabe T, Takahashi K and Nagawa H:
Epigallocatechin gallate, the main component of tea polyphenol,
binds to CD4 and interferes with gp120 binding. J Allergy Clin
Immunol. 112:951–957. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Iida Y, H Tsuno N, Kishikawa J, Kaneko K,
Murono K, Kawai K, Ikeda T, Ishihara S, Yamaguchi H, Sunami E, et
al: Lysophosphatidylserine stimulates chemotactic migration of
colorectal cancer cells through GPR34 and PI3K/Akt pathway.
Anticancer Res. 34:5465–5472. 2014.PubMed/NCBI
|
|
34
|
Banyard J and Bielenberg DR: The role of
EMT and MET in cancer dissemination. Connect Tissue Res.
56:403–413. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Keith B and Simon MC: Hypoxia-inducible
factors, stem cells, and cancer. Cell. 129:465–472. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Soeda A, Park M, Lee D, Mintz A,
Androutsellis-Theotokis A, McKay RD, Engh J, Iwama T, Kunisada T,
Kassam AB, et al: Hypoxia promotes expansion of the CD133-positive
glioma stem cells through activation of HIF-1alpha. Oncogene.
28:3949–3959. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Vu T and Datta PK: Regulation of EMT in
colorectal cancer: a culprit in metastasis. Cancers (Basel).
9:1712017. View Article : Google Scholar
|
|
38
|
Valenta T, Hausmann G and Basler K: The
many faces and functions of β-catenin. EMBO J. 31:2714–2736. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ding Q, Miyazaki Y, Tsukasa K, Matsubara
S, Yoshimitsu M and Takao S: CD133 facilitates
epithelial-mesenchymal transition through interaction with the ERK
pathway in pancreatic cancer metastasis. Mol Cancer. 13:152014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bukholm IK, Nesland JM and Børresen-Dale
AL: Re-expression of E-cadherin, alpha-catenin and beta-catenin,
but not of gamma-catenin, in metastatic tissue from breast cancer
patients [seecomments]. J Pathol. 190:15–19. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Manzo G: Similarities between embryo
development and cancer process suggest new strategies for research
and therapy of tumors: a new point of view. Front Cell Dev Biol.
7:202019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ata R and Antonescu CN: Integrins and cell
metabolism: an intimate relationship impacting cancer. Int J Mol
Sci. 18:1892017. View Article : Google Scholar
|
|
44
|
Koike T, Kimura N, Miyazaki K, Yabuta T,
Kumamoto K, Takenoshita S, Chen J, Kobayashi M, Hosokawa M,
Taniguchi A, et al: Hypoxia induces adhesion molecules on cancer
cells: A missing link between Warburg effect and induction of
selectin-ligand carbohydrates. Proc Natl Acad Sci USA.
101:8132–8137. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ju JA, Godet I, Ye IC, Byun J, Jayatilaka
H, Lee SJ, Xiang L, Samanta D, Lee MH, Wu PH, et al: Hypoxia
selectively enhances integrin α5β1 receptor expression in breast
cancer to promote metastasis. Mol Cancer Res. 15:723–734. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ryu MH, Park HM, Chung J, Lee CH and Park
HR: Hypoxia-inducible factor-1alpha mediates oral squamous cell
carcinoma invasion via upregulation of alpha5 integrin and
fibronectin. Biochem Biophys Res Commun. 393:11–15. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wu X, Cai J, Zuo Z and Li J: Collagen
facilitates the colorectal cancer stemness and metastasis through
an integrin/PI3K/AKT/ Snail signaling pathway. Biomed Pharmacother.
114:1087082019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen WC, Chang YS, Hsu HP, Yen MC, Huang
HL, Cho CY, Wang CY, Weng TY, Lai PT, Chen CS, et al: Therapeutics
targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer.
Oncotarget. 6:42923–42937. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Nakashio T, Narita T, Akiyama S, Kasai Y,
Kondo K, Ito K, Takagi H and Kannagi R: Adhesion molecules and
TGF-beta1 are involved in the peritoneal dissemination of NUGC-4
human gastric cancer cells. Int J Cancer. 70:612–618. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Strobel T and Cannistra SA:
Beta1-integrins partly mediate binding of ovarian cancer cells to
peritoneal mesothelium in vitro. Gynecol Oncol. 73:362–367. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hosono J, Narita T, Kimura N, Sato M,
Nakashio T, Kasai Y, Nonami T, Nakao A, Takagi H and Kannagi R:
Involvement of adhesion molecules in metastasis of SW1990, human
pancreatic cancer cells. J Surg Oncol. 67:77–84. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhang H, Yang N, Sun B, Jiang Y, Hou C, Ji
C, Zhang Y, Liu Y and Zuo P: CD133 positive cells isolated from
A549 cell line exhibited high liver metastatic potential.
Neoplasma. 61:153–160. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Jing F, Kim HJ, Kim CH, Kim YJ, Lee JH and
Kim HR: Colon cancer stem cell markers CD44 and CD133 in patients
with colorectal cancer and synchronous hepatic metastases. Int J
Oncol. 46:1582–1588. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Huang X, Sheng Y and Guan M: Co-expression
of stem cell genes CD133 and CD44 in colorectal cancers with early
liver metastasis. Surg Oncol. 21:103–107. 2012. View Article : Google Scholar : PubMed/NCBI
|
